Utrecht University
Utrecht, 3508TB, Netherlands
NCT Number: NCT01007877
Rationale: Sleepiness behind the wheel is the cause of many traffic accidents. It is claimed that a 15-minute break and consuming an energy drink such as Red Bull® Energy Drink counteracts driver sleepiness.
Objective: The objective of this study is to compare driving simulator performance after (1) a 15-minute break with placebo, (2) a 15-minute break with Red Bull® Energy Drink, and (3) continued driving.
Study design: A double-blind, placebo-controlled crossover study. Study population: Healthy human volunteers, 21-35 years old.
Intervention: Each subject performs 3 test days:
1. 4 hours continued driving 2. 2 hours driving, a 15-minute break + Red Bull® Energy Drink, followed by 2 hours driving 3. 2 hours driving, a 15-minute break + placebo, followed by 2 hours driving Main study parameters/endpoints: Standard Deviation of Lateral Position (SDLP), i.e. the weaving of the car.
Looking for future studies?
Notify Me21 year–35 year
All sexes
Interventional
Not applicable
Utrecht, 3508TB, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During a 15 minute break, subjects consume 250 ml of Red Bull® Energy Drink or placebo. Before and after the break, a 2 hour driving test is scheduled.
Time frame: the 2 hours of driving following the intervention
Time frame: the 2 hours of driving following the intervention
Utrecht Institute for Pharmaceutical Sciences
Other
'Study to Investigate the Effects of an Energy Drink During a 15-minute Break Versus Continued Driving on Driving Performance in the STISIM Driving Simulator'
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01697189
Driver Sleepiness, Pathological Conditions, Signs and Symptoms
Helsinki, Finland
View Trial DetailsNCT05615584
Cataplexy, Disorders of Excessive Somnolence
Montpellier, France
View Trial DetailsNCT06586138
Anxiety Disorders, Apnea
Lyon, France
View Trial DetailsNCT07320131
Behavior, Healthy Participants
Istanbul, Turkey (Türkiye)
View Trial Details